NOCIL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 5:47 am

Market Cap	3,359 Cr.
Current Price	201
High / Low	336/155
Stock P/E	32.7
Book Value	106
Dividend Yield	0.99 %
ROCE	6.65 %
ROE	5.94 %
Face Value	10.0
PEG Ratio	4.79

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for NOCIL Ltd

Competitors of NOCIL Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Hindustan Fluoro Carbons Ltd	26.4 Cr.	13.5	22.6/10.8	62.8	42.0	0.00 %	1.02 %	%	10.0
Gujarat Petrosynthese Ltd	37.0 Cr.	61.9	86.7/52.1	25.3	83.6	0.00 %	4.51 %	2.97 %	10.0
AVI Polymers Ltd	6.05 Cr.	14.8	20.7/9.89	7.38	13.9	0.00 %	19.2 %	15.6 %	10.0
Supreme Petrochem Ltd	14,303 Cr.	762	927/518	38.8	119	1.31 %	22.8 %	17.4 %	2.00
Signet Industries Ltd	189 Cr.	64.3	95.4/39.0	12.1	79.5	0.78 %	13.7 %	6.89 %	10.0
Industry Average	4,314.71 Cr	197.44		33.77	81.32	0.79%	14.65%	13.17%	7.55

All Competitor Stocks of NOCIL Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	463	509	389	326	393	397	351	341	356	372	363	318	340
Expenses	351	406	327	288	343	341	306	292	312	331	325	294	305
Operating Profit	111	103	62	38	50	56	45	49	45	41	38	24	34
OPM %	24%	20%	16%	12%	13%	14%	13%	14%	13%	11%	10%	8%	10%
Other Income	1	0	1	2	3	5	5	6	25	9	8	9	6
Interest	0	0	0	0	0	0	0	0	0	0	1	0	0
Depreciation	16	14	14	14	14	13	13	13	13	13	13	14	13
Profit before tax	96	90	49	25	39	47	37	41	56	37	32	19	26
Tax %	28%	26%	26%	26%	26%	27%	26%	26%	25%	26%	-30%	32%	20%
Net Profit	69	66	36	19	28	34	27	30	42	27	42	13	21
EPS in Rs	4.14	3.99	2.14	1.12	1.70	2.06	1.63	1.80	2.49	1.62	2.52	0.77	1.24

Last Updated: May 31, 2025, 8:16 am

Below is a detailed analysis of the quarterly data for NOCIL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 340.00 Cr.. The value appears strong and on an upward trend. It has increased from 318.00 Cr. (Dec 2024) to 340.00 Cr., marking an increase of 22.00 Cr..
For Expenses, as of Mar 2025, the value is 305.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 294.00 Cr. (Dec 2024) to 305.00 Cr., marking an increase of 11.00 Cr..
For Operating Profit, as of Mar 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Dec 2024) to 34.00 Cr., marking an increase of 10.00 Cr..
For OPM %, as of Mar 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Dec 2024) to 10.00%, marking an increase of 2.00%.
For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.00 Cr. (Dec 2024) to 13.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Dec 2024) to 26.00 Cr., marking an increase of 7.00 Cr..
For Tax %, as of Mar 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Dec 2024) to 20.00%, marking a decrease of 12.00%.
For Net Profit, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Dec 2024) to 21.00 Cr., marking an increase of 8.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 1.24. The value appears strong and on an upward trend. It has increased from 0.77 (Dec 2024) to 1.24, marking an increase of 0.47.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:20 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	488	596	719	715	742	964	1,043	846	925	1,571	1,617	1,445	1,410
Expenses	467	534	605	575	582	695	750	668	793	1,284	1,364	1,250	1,262
Operating Profit	21	62	114	140	160	269	293	178	132	288	253	195	148
OPM %	4%	10%	16%	20%	22%	28%	28%	21%	14%	18%	16%	14%	10%
Other Income	36	9	3	3	9	11	10	9	14	2	6	39	52
Interest	4	17	17	9	2	1	1	1	1	1	1	2	2
Depreciation	9	19	14	15	20	24	24	34	37	48	56	53	53
Profit before tax	44	35	86	119	147	255	278	152	107	241	202	180	144
Tax %	4%	32%	34%	34%	34%	33%	33%	14%	17%	27%	26%	26%
Net Profit	42	24	57	78	97	170	185	131	88	176	149	133	124
EPS in Rs	2.62	1.48	3.55	4.87	5.94	10.33	11.17	7.89	5.32	10.57	8.95	7.98	7.40
Dividend Payout %	23%	40%	28%	25%	30%	24%	22%	32%	38%	28%	34%	38%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-42.86%	137.50%	36.84%	24.36%	75.26%	8.82%	-29.19%	-32.82%	100.00%	-15.34%	-10.74%
Change in YoY Net Profit Growth (%)	0.00%	180.36%	-100.66%	-12.48%	50.90%	-66.43%	-38.01%	-3.64%	132.82%	-115.34%	4.60%

NOCIL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	10%
3 Years:	-4%
TTM:	-4%

Compounded Profit Growth
10 Years:	6%
5 Years:	-4%
3 Years:	-16%
TTM:	-12%

Stock Price CAGR
10 Years:	18%
5 Years:	17%
3 Years:	-7%
1 Year:	-24%

Return on Equity
10 Years:	11%
5 Years:	8%
3 Years:	8%
Last Year:	6%

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 2:59 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	161	161	161	164	164	165	166	166	167	167	167	167
Reserves	217	254	309	750	882	998	1,020	1,119	1,279	1,385	1,532	1,595
Borrowings	152	147	26	15	5	0	7	6	6	10	13	10
Other Liabilities	203	193	186	233	279	279	250	324	380	295	304	284
Total Liabilities	732	755	682	1,161	1,331	1,442	1,442	1,615	1,830	1,857	2,015	2,057
Fixed Assets	320	311	307	543	528	657	797	918	909	888	870	855
CWIP	3	3	6	4	42	131	156	14	8	9	16	60
Investments	22	22	22	176	281	130	54	68	53	218	399	366
Other Assets	386	418	347	438	480	524	434	614	859	742	730	776
Total Assets	732	755	682	1,161	1,331	1,442	1,442	1,615	1,830	1,857	2,015	2,057

Below is a detailed analysis of the balance sheet data for NOCIL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 167.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 167.00 Cr..
For Reserves, as of Mar 2025, the value is 1,595.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,532.00 Cr. (Mar 2024) to 1,595.00 Cr., marking an increase of 63.00 Cr..
For Borrowings, as of Mar 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 13.00 Cr. (Mar 2024) to 10.00 Cr., marking a decrease of 3.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 284.00 Cr.. The value appears to be improving (decreasing). It has decreased from 304.00 Cr. (Mar 2024) to 284.00 Cr., marking a decrease of 20.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 2,057.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,015.00 Cr. (Mar 2024) to 2,057.00 Cr., marking an increase of 42.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 855.00 Cr.. The value appears to be declining and may need further review. It has decreased from 870.00 Cr. (Mar 2024) to 855.00 Cr., marking a decrease of 15.00 Cr..
For CWIP, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2024) to 60.00 Cr., marking an increase of 44.00 Cr..
For Investments, as of Mar 2025, the value is 366.00 Cr.. The value appears to be declining and may need further review. It has decreased from 399.00 Cr. (Mar 2024) to 366.00 Cr., marking a decrease of 33.00 Cr..
For Other Assets, as of Mar 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 730.00 Cr. (Mar 2024) to 776.00 Cr., marking an increase of 46.00 Cr..
For Total Assets, as of Mar 2025, the value is 2,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,015.00 Cr. (Mar 2024) to 2,057.00 Cr., marking an increase of 42.00 Cr..

Notably, the Reserves (1,595.00 Cr.) exceed the Borrowings (10.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	21.00	-90.00	-33.00	114.00	145.00	264.00	293.00	171.00	126.00	282.00	243.00	182.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	83	90	85	77	82	92	81	88	122	104	78	86
Inventory Days	134	167	176	135	116	129	133	128	120	141	117	100
Days Payable	76	122	79	74	82	96	77	84	123	91	52	53
Cash Conversion Cycle	141	136	182	138	116	125	138	132	119	154	143	133
Working Capital Days	92	93	109	86	86	94	99	104	115	129	108	110
ROCE %	5%	10%	19%	24%	21%	26%	25%	13%	9%	18%	13%	10%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	33.85%	33.85%	33.84%	33.84%	33.84%	33.84%	33.84%	33.84%	33.84%	33.84%	33.78%	33.78%
FIIs	2.54%	2.94%	4.46%	5.29%	5.39%	5.44%	6.36%	6.98%	7.77%	7.77%	7.92%	7.82%
DIIs	4.26%	4.87%	5.11%	4.74%	5.49%	4.68%	3.61%	2.83%	3.51%	4.44%	6.13%	5.93%
Public	59.35%	58.34%	56.58%	56.12%	55.27%	56.04%	56.19%	56.36%	54.87%	53.95%	52.18%	52.47%
No. of Shareholders	1,95,204	1,88,230	1,81,823	1,81,692	1,77,869	1,79,495	1,81,190	1,76,347	1,71,496	1,67,157	1,66,627	1,63,899

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Canara Robeco Small Cap Fund	1,085,617	0.26	27.48	1,085,617	2025-04-22 17:25:24	0%
Aditya Birla Sun Life Business Cycle Fund	841,512	1.25	21.3	841,512	2025-04-22 17:25:24	0%
HSBC Value Fund	776,500	0.16	19.65	776,500	2025-04-22 17:25:24	0%
Edelweiss Small Cap Fund	771,979	0.57	19.54	771,979	2025-04-22 17:25:24	0%
Bandhan Small Cap Fund	485,631	0.24	12.29	485,631	2025-04-22 17:25:24	0%
Canara Robeco Manufacturing Fund	453,736	0.84	11.48	453,736	2025-04-22 17:25:24	0%
Aditya Birla Sun Life Manufacturing Equity Fund	286,652	0.72	7.26	286,652	2025-04-22 17:25:24	0%
Taurus ELSS Tax Saver Fund	38,665	1.31	0.98	38,665	2025-04-22 17:25:24	0%
IDBI Hybrid Equity Fund	32,613	0.4	0.72	32,613	2025-04-22 17:25:24	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	7.98	8.95	10.58	5.33	7.89
Diluted EPS (Rs.)	7.95	8.92	10.55	5.32	7.89
Cash EPS (Rs.)	11.15	12.29	13.47	7.57	9.93
Book Value[Excl.RevalReserv]/Share (Rs.)	101.92	93.14	86.76	77.29	71.57
Book Value[Incl.RevalReserv]/Share (Rs.)	101.92	93.14	86.76	77.29	71.57
Revenue From Operations / Share (Rs.)	86.69	97.01	94.33	55.63	51.10
PBDIT / Share (Rs.)	14.07	15.54	17.41	8.76	11.32
PBIT / Share (Rs.)	10.90	12.20	14.51	6.50	9.28
PBT / Share (Rs.)	10.80	12.13	14.45	6.45	9.20
Net Profit / Share (Rs.)	7.98	8.95	10.57	5.32	7.89
NP After MI And SOA / Share (Rs.)	7.98	8.95	10.57	5.32	7.89
PBDIT Margin (%)	16.22	16.01	18.45	15.73	22.14
PBIT Margin (%)	12.57	12.57	15.38	11.69	18.15
PBT Margin (%)	12.45	12.50	15.31	11.58	18.00
Net Profit Margin (%)	9.20	9.22	11.20	9.56	15.44
NP After MI And SOA Margin (%)	9.20	9.22	11.20	9.56	15.44
Return on Networth / Equity (%)	7.83	9.60	12.18	6.88	11.02
Return on Capital Employeed (%)	9.81	12.05	15.38	7.69	11.80
Return On Assets (%)	6.59	8.03	9.62	5.47	9.06
Asset Turnover Ratio (%)	0.74	0.88	0.91	0.60	0.58
Current Ratio (X)	5.89	5.15	3.25	2.96	3.03
Quick Ratio (X)	4.55	3.49	1.97	2.17	2.06
Inventory Turnover Ratio (X)	3.08	2.94	3.79	3.17	2.39
Dividend Payout Ratio (NP) (%)	37.58	33.50	18.89	0.00	76.35
Dividend Payout Ratio (CP) (%)	26.90	24.40	14.82	0.00	60.68
Earning Retention Ratio (%)	62.42	66.50	81.11	0.00	23.65
Cash Earning Retention Ratio (%)	73.10	75.60	85.18	0.00	39.32
Interest Coverage Ratio (X)	144.69	215.81	266.10	150.03	141.97
Interest Coverage Ratio (Post Tax) (X)	83.10	125.29	162.57	92.14	99.99
Enterprise Value (Cr.)	4059.04	3380.38	4139.10	2821.79	1075.88
EV / Net Operating Revenue (X)	2.81	2.09	2.63	3.05	1.27
EV / EBITDA (X)	17.32	13.05	14.27	19.39	5.74
MarketCap / Net Operating Revenue (X)	2.88	2.13	2.64	3.14	1.29
Retention Ratios (%)	62.41	66.49	81.10	0.00	23.64
Price / BV (X)	2.45	2.21	2.88	2.26	0.91
Price / Net Operating Revenue (X)	2.88	2.13	2.64	3.14	1.29
EarningsYield	0.03	0.04	0.04	0.03	0.11

After reviewing the key financial ratios for NOCIL Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 7.98. This value is within the healthy range. It has decreased from 8.95 (Mar 23) to 7.98, marking a decrease of 0.97.
For Diluted EPS (Rs.), as of Mar 24, the value is 7.95. This value is within the healthy range. It has decreased from 8.92 (Mar 23) to 7.95, marking a decrease of 0.97.
For Cash EPS (Rs.), as of Mar 24, the value is 11.15. This value is within the healthy range. It has decreased from 12.29 (Mar 23) to 11.15, marking a decrease of 1.14.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.92. It has increased from 93.14 (Mar 23) to 101.92, marking an increase of 8.78.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.92. It has increased from 93.14 (Mar 23) to 101.92, marking an increase of 8.78.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 86.69. It has decreased from 97.01 (Mar 23) to 86.69, marking a decrease of 10.32.
For PBDIT / Share (Rs.), as of Mar 24, the value is 14.07. This value is within the healthy range. It has decreased from 15.54 (Mar 23) to 14.07, marking a decrease of 1.47.
For PBIT / Share (Rs.), as of Mar 24, the value is 10.90. This value is within the healthy range. It has decreased from 12.20 (Mar 23) to 10.90, marking a decrease of 1.30.
For PBT / Share (Rs.), as of Mar 24, the value is 10.80. This value is within the healthy range. It has decreased from 12.13 (Mar 23) to 10.80, marking a decrease of 1.33.
For Net Profit / Share (Rs.), as of Mar 24, the value is 7.98. This value is within the healthy range. It has decreased from 8.95 (Mar 23) to 7.98, marking a decrease of 0.97.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 7.98. This value is within the healthy range. It has decreased from 8.95 (Mar 23) to 7.98, marking a decrease of 0.97.
For PBDIT Margin (%), as of Mar 24, the value is 16.22. This value is within the healthy range. It has increased from 16.01 (Mar 23) to 16.22, marking an increase of 0.21.
For PBIT Margin (%), as of Mar 24, the value is 12.57. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 12.57.
For PBT Margin (%), as of Mar 24, the value is 12.45. This value is within the healthy range. It has decreased from 12.50 (Mar 23) to 12.45, marking a decrease of 0.05.
For Net Profit Margin (%), as of Mar 24, the value is 9.20. This value is within the healthy range. It has decreased from 9.22 (Mar 23) to 9.20, marking a decrease of 0.02.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.20. This value is within the healthy range. It has decreased from 9.22 (Mar 23) to 9.20, marking a decrease of 0.02.
For Return on Networth / Equity (%), as of Mar 24, the value is 7.83. This value is below the healthy minimum of 15. It has decreased from 9.60 (Mar 23) to 7.83, marking a decrease of 1.77.
For Return on Capital Employeed (%), as of Mar 24, the value is 9.81. This value is below the healthy minimum of 10. It has decreased from 12.05 (Mar 23) to 9.81, marking a decrease of 2.24.
For Return On Assets (%), as of Mar 24, the value is 6.59. This value is within the healthy range. It has decreased from 8.03 (Mar 23) to 6.59, marking a decrease of 1.44.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.74. It has decreased from 0.88 (Mar 23) to 0.74, marking a decrease of 0.14.
For Current Ratio (X), as of Mar 24, the value is 5.89. This value exceeds the healthy maximum of 3. It has increased from 5.15 (Mar 23) to 5.89, marking an increase of 0.74.
For Quick Ratio (X), as of Mar 24, the value is 4.55. This value exceeds the healthy maximum of 2. It has increased from 3.49 (Mar 23) to 4.55, marking an increase of 1.06.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.08. This value is below the healthy minimum of 4. It has increased from 2.94 (Mar 23) to 3.08, marking an increase of 0.14.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 37.58. This value is within the healthy range. It has increased from 33.50 (Mar 23) to 37.58, marking an increase of 4.08.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 26.90. This value is within the healthy range. It has increased from 24.40 (Mar 23) to 26.90, marking an increase of 2.50.
For Earning Retention Ratio (%), as of Mar 24, the value is 62.42. This value is within the healthy range. It has decreased from 66.50 (Mar 23) to 62.42, marking a decrease of 4.08.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 73.10. This value exceeds the healthy maximum of 70. It has decreased from 75.60 (Mar 23) to 73.10, marking a decrease of 2.50.
For Interest Coverage Ratio (X), as of Mar 24, the value is 144.69. This value is within the healthy range. It has decreased from 215.81 (Mar 23) to 144.69, marking a decrease of 71.12.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 83.10. This value is within the healthy range. It has decreased from 125.29 (Mar 23) to 83.10, marking a decrease of 42.19.
For Enterprise Value (Cr.), as of Mar 24, the value is 4,059.04. It has increased from 3,380.38 (Mar 23) to 4,059.04, marking an increase of 678.66.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.81. This value is within the healthy range. It has increased from 2.09 (Mar 23) to 2.81, marking an increase of 0.72.
For EV / EBITDA (X), as of Mar 24, the value is 17.32. This value exceeds the healthy maximum of 15. It has increased from 13.05 (Mar 23) to 17.32, marking an increase of 4.27.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.88. This value is within the healthy range. It has increased from 2.13 (Mar 23) to 2.88, marking an increase of 0.75.
For Retention Ratios (%), as of Mar 24, the value is 62.41. This value is within the healthy range. It has decreased from 66.49 (Mar 23) to 62.41, marking a decrease of 4.08.
For Price / BV (X), as of Mar 24, the value is 2.45. This value is within the healthy range. It has increased from 2.21 (Mar 23) to 2.45, marking an increase of 0.24.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.88. This value is within the healthy range. It has increased from 2.13 (Mar 23) to 2.88, marking an increase of 0.75.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of NOCIL Ltd as of June 13, 2025 is: 166.34

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 13, 2025, NOCIL Ltd is Overvalued by 17.24% compared to the current share price 201.00

Intrinsic Value of NOCIL Ltd as of June 13, 2025 is: 177.69

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 13, 2025, NOCIL Ltd is Overvalued by 11.60% compared to the current share price 201.00

Last 5 Year EPS CAGR: 6.82%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 16.08%, which is a positive sign. The company has higher reserves (945.00 cr) compared to borrowings (33.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (461.54 cr) and profit (153.08 cr) over the years.	The stock has a high average Working Capital Days of 102.08, which may not be favorable. The stock has a high average Cash Conversion Cycle of 138.08, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in NOCIL Ltd:
1. Net Profit Margin: 9.2%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 9.81% (Industry Average ROCE: 14.65%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 7.83% (Industry Average ROE: 13.17%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 83.1
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 4.55
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 32.7 (Industry average Stock P/E: 33.77)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

NOCIL Ltd. is a Public Limited Listed company incorporated on 11/05/1961 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1961PLC012003 and registration number is 012003. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1392.69 Cr. and Equity Capital is Rs. 167.02 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Petrochemicals - Polymers	Mafatlal House, H T Parekh Marg, Mumbai Maharashtra 400020	investorcare@nocil.com http://www.nocil.com

Management
Name	Position Held
Mr. Hrishikesh A Mafatlal	Executive Chairman
Mr. Anand V S	Managing Director
Mr. Priyavrata H Mafatlal	Non Independent Director
Mr. Rohit Arora	Independent Director
Mr. Vilas R Gupte	Independent Director
Mr. D N Mungale	Independent Director
Mr. P V Bhide	Independent Director
Ms. Dharmishta N Raval	Independent Director
Mr. Debnarayan Bhattacharya	Independent Director
Mr. A Vellayan	Independent Director
Mr. Sujal Shah	Independent Director
Mr. Ramesh Iyer	Independent Director
Ms. Radhika Haribhakti	Independent Director

FAQ

What is the intrinsic value of NOCIL Ltd?

NOCIL Ltd's intrinsic value (as of 13 June 2025) is ₹166.34 — 17.24% lower the current market price of 201.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,359 Cr. market cap, FY2025-2026 high/low of ₹336/155, reserves of 1,595 Cr, and liabilities of 2,057 Cr.

What is the Market Cap of NOCIL Ltd?

The Market Cap of NOCIL Ltd is 3,359 Cr..

What is the current Stock Price of NOCIL Ltd as on 13 June 2025?

The current stock price of NOCIL Ltd as on 13 June 2025 is 201.

What is the High / Low of NOCIL Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of NOCIL Ltd stocks is ₹336/155.

What is the Stock P/E of NOCIL Ltd?

The Stock P/E of NOCIL Ltd is 32.7.

What is the Book Value of NOCIL Ltd?

The Book Value of NOCIL Ltd is 106.

What is the Dividend Yield of NOCIL Ltd?

The Dividend Yield of NOCIL Ltd is 0.99 %.

What is the ROCE of NOCIL Ltd?

The ROCE of NOCIL Ltd is 6.65 %.

What is the ROE of NOCIL Ltd?

The ROE of NOCIL Ltd is 5.94 %.

What is the Face Value of NOCIL Ltd?

The Face Value of NOCIL Ltd is 10.0.